Asia-Pacific guidelines for managing functional dyspepsia overlapping with other gastrointestinal symptoms

• Published in: Journal of Gastroenterology and Hepatology (Australia)
• Main Author: Gwee K.-A.; Lee Y.Y.; Suzuki H.; Ghoshal U.C.; Holtmann G.; Bai T.; Barbara G.; Chen M.-H.; Chua A.S.B.; Gibson P.R.; Hou X.; Liu J.; Nakajima A.; Pratap N.; Sachdeva S.; Siah K.T.H.; Soh A.Y.S.; Sugano K.; Tack J.; Tan V.P.Y.; Tang X.; Walker M.; Wu D.-C.; Xiao Y.-L.; Zulkifli K.K.; Toh C.
• Format: Review
• Language: English
• Published: John Wiley and Sons Inc 2023
• Online Access: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85143402646&doi=10.1111%2fjgh.16046&partnerID=40&md5=8ab763f8aa7a5e619c58cc1492388683

Contemporary systems for the diagnosis and management gastrointestinal symptoms not attributable to organic diseases (Functional GI Disorders, FGID, now renamed Disorders of Gut-Brain Interaction, DGBI) seek to categorize patients into narrowly defined symptom-based sub-classes to enable targeted treatment of patient cohorts with similar underlying putative pathophysiology. However, an overlap of symptom categories frequently occurs and has a negative impact on treatment outcomes. There is a lack of guidance on their management. An Asian Pacific Association of Gastroenterology (APAGE) working group was set up to develop clinical practice guidelines for management of patients with functional dyspepsia (FD) who have an overlap with another functional gastrointestinal disorder: FD with gastroesophageal reflux (FD-GERD), epigastric pain syndrome with irritable bowel syndrome (EPS-IBS), postprandial distress syndrome with IBS (PDS-IBS), and FD-Constipation. We identified putative pathophysiology to provide a basis for treatment recommendations. A management algorithm is presented to guide primary and secondary care clinicians. © 2022 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.